Anxiety Disorders Completed Phase 4 Trials for Lorazepam (DB00186)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00044642Lorazepam-Induced Toxicity in the AgedDiagnostic